{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:28:55Z","timestamp":1789122535923,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The C-reactive protein\/Lymphocyte Ratio (CLR) is a novel biomarker whose role in the development of chronic kidney disease (CKD) is not well understood. This study aimed to investigate the correlation between CLR and the prevalence of CKD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study included participants from the US National Health and Nutrition Examination Survey conducted between 1999 and 2010. Multivariate regression analyses and subgroup analyses were performed, controlling for socio-demographic variables, lifestyle behaviors, chronic diseases associated with kidney disease, and biochemical markers of bone metabolism. The associations between CLR and CKD prevalence, as well as indicators of renal damage, were explored. Non-linear relationships were analyzed using weighted restricted cubic splines. The predictive ability of CLR for CKD was assessed by the receiver operating characteristic curve and the area under the curve was calculated. Subgroup and sensitivity analyses were conducted to validate the robustness of the model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 13,862 respondents were included, comprising 2,449 CKD patients and 11,413 non-CKD patients. Weighted logistic regression modeling revealed a positive correlation between CLR levels and CKD prevalence (Odds ratio [OR] = 1.54, 95% Confidence interval [CI] = 1.30 to 1.83, P &amp;lt; 0.001). Additionally, CLR levels were negatively correlated with the glomerular filtration rate, a marker of renal injury, and positively correlated with the urinary albumin\/creatinine ratio. The receiver operating characteristic curve demonstrated that the area under the curve for CLR in predicting CKD was 0.653 (95% CI, 0.641\u20130.665). The optimal cutoff value was 0.856, with a sensitivity of 0.703, specificity of 0.526, positive predictive value of 0.874, and negative predictive value of 0.275. The robustness of the model was confirmed through subgroup and sensitivity analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Analysis of a large cross-sectional dataset demonstrated a positive correlation between CLR levels and CKD prevalence, suggesting that CLR may serve as a novel marker for the development and treatment of CKD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1469750","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:10:37Z","timestamp":1736917837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The relationship between C-reactive protein to lymphocyte ratio and the prevalence of chronic kidney disease in US adults: a cross-sectional study"],"prefix":"10.3389","volume":"15","author":[{"given":"Pengfei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (Isn-Kddc): A cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.3390\/ijms221810084","article-title":"Chronic kidney disease: strategies to retard progression","volume":"22","author":"Yan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/ijms18050950","article-title":"Hypoxia, Hif, and associated signaling networks in chronic kidney disease","volume":"18","author":"Liu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.661203","article-title":"Microbiome, immunosenescence, and chronic kidney disease","volume":"8","author":"Stavropoulou","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020182","article-title":"Review on inflammation markers in chronic kidney disease","volume":"9","author":"Petreski","year":"2021","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2024.01.002","article-title":"Comprehensive assessment of the combined impact of dyslipidemia and inflammation on chronic kidney disease development: A prospective cohort study","volume":"18","author":"Yoon","year":"2024","journal-title":"J Clin Lipidol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.13121215","article-title":"Inflammation and progression of Ckd: the Cric study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15268","article-title":"Inflammation and trajectory of renal function in community-dwelling older adults","volume":"66","author":"Salimi","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1331610","article-title":"Systemic immune-inflammation index is associated with chronic kidney disease in the U.S. Population: insights from Nhanes 2007-2018","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.arbres.2020.07.038","article-title":"The value of C-reactive protein-to-lymphocyte ratio in predicting the severity of Sars-Cov-2 pneumonia","volume":"57","author":"Cill\u00f3niz","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12957-021-02319-x","article-title":"Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer","volume":"19","author":"Nishi","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.24875\/ciru.22000124","article-title":"C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with Covid-19 infection: the clear Covid study","volume":"90","author":"Demirkol","year":"2022","journal-title":"Cir Cir"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1960768","article-title":"Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer","volume":"12","author":"Meng","year":"2021","journal-title":"Bioengineered"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.910222","article-title":"C-reactive protein to lymphocyte ratio as a new biomarker in predicting surgical site infection after posterior lumbar interbody fusion and instrumentation","volume":"9","author":"Wu","year":"2022","journal-title":"Front Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000001273","article-title":"C-reactive protein\/lymphocyte ratio as a prognostic biomarker in acute pancreatitis: A cross-sectional study assessing disease severity","volume":"110","author":"Chen","year":"2024","journal-title":"Int J Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"18889","DOI":"10.1038\/s41598-023-46338-y","article-title":"Exploring the diagnostic and prognostic value of the C-reactive protein\/lymphocyte ratio for dilated cardiomyopathy based on a real-world study","volume":"13","author":"Qi","year":"2023","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17776","article-title":"The relationship between C-reactive protein to lymphocyte ratio and the prevalence of myocardial infarction in us adults: A cross-sectional study","volume":"9","author":"He","year":"2023","journal-title":"Heliyon"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25819","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (Covid-19): A meta-analysis","volume":"92","author":"Lagunas-Rangel","year":"2020","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the Kdigo 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117159","article-title":"Analysis of brominated flame retardants exposure-associated chronic kidney disease risk in the US population from the Nhanes","volume":"286","author":"Tao","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvab278","article-title":"National kidney foundation laboratory engagement working group recommendations for implementing the ckd-epi 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories","volume":"68","author":"Miller","year":"2022","journal-title":"Clin Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft338","article-title":"Anemia management in non-dialysis chronic kidney disease (Ckd) patients: A multicenter prospective study in renal clinics","volume":"28","author":"Minutolo","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1251232","article-title":"The correlation of urinary strontium with the risk of chronic kidney disease among the general United States population","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Public Health"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8915","article-title":"Selecting the model for multiple imputation of missing data: just use an Ic","volume":"40","author":"Noghrehchi","year":"2021","journal-title":"Stat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2013.779373","article-title":"Oxidative stress in patients with cardiovascular disease and chronic renal failure","volume":"47","author":"Popolo","year":"2013","journal-title":"Free Radic Res"},{"key":"B28","article-title":"Chronic inflammation","volume-title":"Statpearls","author":"Pahwa","year":"2024"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000534447","article-title":"Chronic inflammation in chronic kidney disease","volume":"148","author":"Yan","year":"2024","journal-title":"Nephron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/cells12121581","article-title":"The role of inflammation in Ckd","volume":"12","author":"Kadatane","year":"2023","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/biom9060223","article-title":"Chronic inflammation as an immunological abnormality and effectiveness of exercise","volume":"9","author":"Suzuki","year":"2019","journal-title":"Biomolecules"},{"key":"B32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00423-010-0658-6","article-title":"Endotoxin elimination in sepsis: physiology and therapeutic application","volume":"395","author":"Buttenschoen","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"BioMed Res Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy175","article-title":"Chronic inflammation in end-stage renal disease and dialysis","volume":"33","author":"Cobo","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00298.2018","article-title":"Chronic kidney disease and the gut microbiome","volume":"316","author":"Hobby","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/toxins12070439","article-title":"Immune dysfunction in uremia 2020","volume":"12","author":"Cohen","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2008.00444.x","article-title":"Hemodialysis central venous catheters as a source of inflammation and its implications","volume":"21","author":"Hung","year":"2008","journal-title":"Semin Dial"},{"key":"B38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000504251","article-title":"The cumulative exposure to high-sensitivity C-reactive protein predicts the risk of chronic kidney diseases","volume":"45","author":"Gao","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.42","article-title":"C-reactive protein\u00a0promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice","volume":"91","author":"Li","year":"2011","journal-title":"Lab Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1042\/cs20230399","article-title":"B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease","volume":"137","author":"Dolade","year":"2023","journal-title":"Clin Sci (Lond)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.742419","article-title":"T-lymphocyte subsets alteration, infection and renal outcome in advanced chronic kidney disease","volume":"8","author":"Xiong","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/bctt.S464161","article-title":"The effect of C-reactive protein\/lymphocyte ratio (Clr) on Pfs\u00a0in metastatic breast cancer patients treated with Cdk4\/6 inhibitors: A novel biomarker","volume":"16","author":"Buyukbayram","year":"2024","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08301-3","article-title":"Prognostic value of the C-reactive protein\/lymphocyte ratio in pancreatic cancer","volume":"27","author":"Fan","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20220236","article-title":"C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear Hep-C study","volume":"68","author":"Demirkol","year":"2022","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4055\/cios22313","article-title":"Can C-reactive protein-lymphocyte ratio be used as a screening tool to confirm the diagnosis of periprosthetic joint infection","volume":"15","author":"Balta","year":"2023","journal-title":"Clin Orthop Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3390\/jpm11121274","article-title":"Prognostic value of C-reactive protein to lymphocyte ratio (Clr) in emergency department patients with sars-cov-2 infection","volume":"11","author":"Tonduangu","year":"2021","journal-title":"J Pers Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/biom13030534","article-title":"Tnfr2 as a potential biomarker for early detection and progression of Ckd","volume":"13","author":"Lousa","year":"2023","journal-title":"Biomolecules"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2020020212","article-title":"Biomarkers of Ckd in children","volume":"31","author":"Al-Aly","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7326\/m23-2814","article-title":"Association of albuminuria with chronic kidney disease progression in persons with chronic kidney disease and normoalbuminuria: A cohort study","volume":"177","author":"Verma","year":"2024","journal-title":"Ann Intern Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000000000377","article-title":"Individualized risk of Ckd progression among us adults","volume":"35","author":"Tio","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.868715","article-title":"Chronic kidney disease and cancer: inter-relationships and mechanisms","volume":"10","author":"Hu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/133936","article-title":"Influence of lipid-lowering drugs on inflammation: what is yet to be done","volume":"18","author":"Ugov\u0161ek","year":"2022","journal-title":"Arch Med Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.11.017","article-title":"Effects of the glucose-lowering rate on Ctni and Hs-Crp serum levels in type 2 diabetics","volume":"74","author":"Wu","year":"2013","journal-title":"Hum Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000001267","article-title":"Influence of hypersensitive C-reactive protein on the effect of continuous antihypertensive pharmacological therapy","volume":"80","author":"Bao","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2020.09.001","article-title":"Metformin and systemic metabolism","volume":"41","author":"He","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11883-021-00977-6","article-title":"Statins and inflammation","volume":"23","author":"Satny","year":"2021","journal-title":"Curr Atheroscler Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1469750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:10:42Z","timestamp":1736917842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1469750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":57,"alternative-id":["10.3389\/fendo.2024.1469750"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1469750","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1469750"}}